Method for prediction of effectiveness of RAR-alpha agonist

Details for Australian Patent Application No. 2006307231 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Murakami, Koji

Agent Watermark

Pub. Number AU-B-2006307231

PCT Pub. Number WO2007/049542

Priority 60/729,175 24.10.05 US; 60/816,616 27.06.06 US

Filing date 23 October 2006

Wipo publication date 3 May 2007

Acceptance publication date 23 June 2011

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/049542 Priority application(s): WO2007/049542

23 June 2011 Application Accepted

  Published as AU-B-2006307231

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006307242-Drug for treating circulatory insufficiency

2006307183-Protector and needle set